Lyubov Shkarupa
Psychiatric/Mental Health · Springfield, NJNPI 1881836443
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,458 of the $10,734 with a category attached, or 78.8%. 25 manufacturers reported payments, led by AbbVie at 39.5% of the total. Reporting peaked in 2023 at $4,520 and has fallen 72.2% since, to $1,256 in 2025. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 483 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$941
- Axsome Therapeutics, Inc.$807
- Takeda Pharmaceuticals U.S.A., Inc.$429
- Neurocrine Biosciences, Inc.$424
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$2,20020%
- Food & beverage$8,45879%
- Education$761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 145 | $4,236 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 67 | $1,612 |
| Otsuka America Pharmaceutical, Inc. | 45 | $941 |
| Axsome Therapeutics, Inc. | 46 | $807 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $429 |
| Neurocrine Biosciences, Inc. | 7 | $424 |
| Alkermes, Inc. | 22 | $361 |
| Sunovion Pharmaceuticals Inc. | 13 | $274 |
| Almatica Pharma LLC | 16 | $249 |
| Bausch Health US, LLC | 20 | $239 |
| Neos Therapeutics, LP | 14 | $219 |
| Lundbeck LLC | 8 | $133 |
| Supernus Pharmaceuticals, Inc. | 6 | $116 |
| Tris Pharma Inc | 4 | $98 |
| Ironshore Pharmaceuticals Inc. | 6 | $92 |
| Corium, LLC | 6 | $91 |
| Teva Pharmaceuticals USA, Inc. | 6 | $80 |
| Jazz Pharmaceuticals Inc. | 5 | $71 |
| Vanda Pharmaceuticals Inc. | 4 | $54 |
| Avanir Pharmaceuticals, Inc. | 3 | $42 |
| Alfasigma USA, Inc. | 3 | $38 |
| Sage Therapeutics, LLC | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$2,445
- CAPLYTA$655
- INGREZZA$367
- ABILIFY ASIMTUFII$222
- ABILIFY MAINTENA$222
- Auvelity$122
- REXULTI$116
How this compares
$10,734 in reported general payments places this provider in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 11 | $2,397 |
| Quetiapine Fumarate | 30 | $1,566 |
| Zolpidem Tartrate ErZolpidem Tartrate | 12 | $1,243 |
| Duloxetine Hcl | 22 | $1,112 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $1,047 |
| Oxcarbazepine | 17 | $1,011 |
| Bupropion XlBupropion Hcl | 66 | $805 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $566 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $514 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $493 |
| Tranylcypromine Sulfate | 11 | $481 |
| Doxepin Hcl | 25 | $462 |
| Mirtazapine | 38 | $388 |
| Haloperidol | 11 | $380 |
| Alprazolam | 96 | $365 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $249 | $4614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Other psychiatric/mental health in Springfield
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.